Skip to content

Yield of Cryoprobe vs Flexible Forceps Pleural Biopsy

A Study to Evaluate the Yield of Pleural Biopsy With a Flexible Cryoprobe Versus Flexible Forceps During Semirigid Thoracoscopy: a Comparative Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02500277
Acronym
COFFEE
Enrollment
50
Registered
2015-07-16
Start date
2015-01-31
Completion date
2018-07-31
Last updated
2018-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Malignancy, Pleural Effusion, Pleurisy, Tuberculosis

Keywords

thoracoscopy, pleuroscopy, semirigid thoracoscopy, flexible cryoprobe, cryobiopsy, pleural biopsy

Brief summary

This is a prospective study to assess the yield of pleural biopsy obtained with the routine flexible thoracoscopic biopsy forceps versus that obtained with a flexible cryoprobe during semirigid thoracoscopy

Detailed description

Consecutive patients with exudative pleural effusions who are planned to undergo semirigid thoracoscopy will be enrolled in the study if they satisfy the inclusion criteria. They will be randomized in 1:1 ratio using a computer-generated randomization sequence to the following groups: Group A: Four pleural biopsy specimens obtained using the flexible cryoprobe followed by eight pleural biopsy specimens obtained using the flexible thoracoscopic forceps OR Group B: The above two procedures will be performed in the reverse order The biopsies will be performed from different areas of the involved pleura with the two techniques. Thoracoscopy will be performed in the bronchoscopy suite on spontaneously breathing subjects (fasting for 8 h) under conscious sedation (using midazolam, pentazocine, and tramadol) observing complete aseptic precautions.

Interventions

DEVICECryoprobe pleural biopsy first

Four pleural biopsy specimens will be obtained using the flexible cryoprobe (ERBOCRYOCA, ERBE, Tubingen, Germany; outer diameter 1.9 mm, length 900 mm) followed by 6-10 pleural biopsy specimens obtained using the flexible thoracoscopic forceps (FB-55CR, Olympus Medical Systems, 2 mm diameter).

DEVICEFlexible forceps biopsy first

Six to ten pleural biopsy specimens will be obtained using the flexible thoracoscopic forceps (FB-55CR, Olympus Medical Systems, 2 mm diameter) followed by four pleural biopsy specimens obtained using the flexible cryoprobe (ERBOCRYOCA, ERBE, Tubingen, Germany; outer diameter 1.9 mm, length 900 mm)

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥12 years * Semirigid thoracoscopy being performed for diagnosis of the pleural effusion

Exclusion criteria

* Age ≥80 years * SpO2 \<88% on room air * Hemodynamic instability * Myocardial infarction or unstable angina in the last 6 wk * Lack of pleural space due to adhesions * Uncorrected coagulopathy * Failure to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Yield of pleural biopsy obtained with the routine flexible thoracoscopic biopsy forceps versus that obtained with a flexible cryoprobe during semirigid thoracoscopyOne weekThe proportion of patients where a definitive histopathological diagnosis was obtained will be compared between the cryoprobe and flexible forceps biopsy

Secondary

MeasureTime frameDescription
Duration of procedureOne dayTime taken for the procedure with the two techniques
Ease of biopsy VASOne dayEase of taking biopsy with the two techniques assessed using a visual analog scale
Biopsy sizeOne daySize of biopsy specimens obtained with the two techniques
Tissue depthOne dayDepth of the tissue obtained on histopathology
BleedingOne dayNumber of participants with bleeding seen while taking biopsy categorised into no bleeding, minimal self limited ooze, bleeding requiring prolonged suctioning , major hemorrhage requiring blood transfusion, causing hemodynamic instability or ICU admission
ArtifactsOne dayNumber of patient speciemens with histopathologic artifacts with either technique including crush artefacts with the flexible forceps and freeze artifacts with the cryoprobe

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026